The European Medicines Agency (EMA) is carrying out a survey to assess how its communications to the general public are perceived and valued by the stakeholders. This will provide valuable feedback to help EMA to better plan and carry out its communication activities. This is the second communications survey, the first took place in 2015.
The survey focuses on EMA communication activities to the general public (i.e. EMA information made public mainly through the EMA website such as press releases and news announcements). It does not relate to communication as part of your regular or professional interaction with EMA (e.g. communications with EMA officials in the context of an evaluation procedure or any other information exchange under working arrangements).
To access the survey, click here. The survey will be open until 31 May 2017.